Total planned funding: $880,580,713
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $142,286,528 |
Kenya | $125,776,113 |
Tanzania | $114,474,675 |
Nigeria | $85,511,789 |
South Africa | $83,152,756 |
Ethiopia | $51,661,342 |
Zambia | $46,024,777 |
Botswana | $28,002,545 |
Rwanda | $26,076,759 |
Malawi | $23,565,623 |
Namibia | $21,170,834 |
Côte d'Ivoire | $19,204,195 |
Democratic Republic of the Congo | $18,519,595 |
Eswatini | $16,695,985 |
Haiti | $16,639,000 |
Uganda | $13,246,450 |
Lesotho | $8,142,197 |
Vietnam | $6,308,728 |
Angola | $6,048,636 |
Caribbean Region | $5,837,200 |
Central Asia Region | $4,090,743 |
South Sudan | $3,792,945 |
Guyana | $2,930,000 |
Central America Region | $2,903,298 |
Zimbabwe | $2,098,000 |
India | $1,700,000 |
Ukraine | $1,600,000 |
Burma | $1,300,000 |
Burundi | $900,000 |
Ghana | $820,000 |
Dominican Republic | $100,000 |
China | $0 |
Russia | $0 |
Organizational Types
University | $880,580,713 |
Program Areas
Treatment | $282,929,940 |
Prevention | $154,159,784 |
Governance and Systems | $120,123,494 |
Care | $108,784,741 |
Testing | $56,976,795 |
Budget Codes
HTXS: Treatment: Adult Treatment | $246,897,686 |
HVSI: Strategic Information | $61,078,112 |
HVCT: Testing: HIV Testing and Counseling | $56,976,795 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $51,843,645 |
HBHC: Care: Adult Care and Support | $48,193,973 |
HVOP: Sexual Prevention: Other Sexual Prevention | $43,603,659 |
OHSS: Health Systems Strengthening | $40,719,521 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $36,777,585 |
PDTX: Treatment: Pediatric Treatment | $32,814,968 |
HVTB: Care: TB/HIV | $31,031,871 |
HLAB: Laboratory Infrastructure | $18,325,861 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,242,534 |
HKID: Care: Orphans and Vulnerable Children | $15,170,207 |
PDCS: Care: Pediatric Care and Support | $14,388,690 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,538,341 |
HTXD: Treatment: ARV Drugs | $3,217,286 |
HMBL: Biomedical Prevention: Blood Safety | $1,178,552 |
HMIN: Biomedical Prevention: Injection Safety | $975,468 |
Top Partner Programs
Columbia University:
$252,701,468
View countries
Johns Hopkins University:
$135,940,538
View countries
Harvard University:
$74,414,261
View countries
University of Maryland:
$70,417,142
View countries
University of Washington:
$59,638,287
View countries